Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Morbid obesity
 
Major Surgical or Invasive Procedure:
___: laparoscopic sleeve gastrectomy

 
History of Present Illness:
Per Dr. ___ has class III morbid obesity with 
weight of 278.3 pounds as of ___ with her weight of 274.1 
pounds on ___, height of 63 inches and BMI of 49.3.  On her 
initial screening visit ___.  She weighed 272.4 pounds with 
a BMI of 47.5 and on ___ she weighed 270.4 pounds.  Her 
previous weight loss efforts have included Weight Watchers, the 
___ diet, RD visits and a medical weight management program 
at the ___.  She has been able to lose 
up to 111 pounds but her weight loss attempts at failed to 
produce lasting results.  She has not taken prescription weight 
loss medications or used over-the-counter ephedra-containing 
appetite suppressants/herbal supplements.  She stated that her 
lowest adult weight was 171 pounds at the age of ___ when she had 
lost 111 pounds with the ___ weight 
loss program.  She weighed 221 pounds ___ years ago, 279 pounds 
___ years ago, 171 pounds her lowest weight in ___, 203 pounds ___ 
years ago with her highest weight 282 pounds in ___.  She 
stated that she has been struggling with weight since childhood 
and cites as factors contributing to her excess weight large 
portions, grazing, convenience eating, emotional eating monthly 
and lack of exercise secondary to physical limitations (had 
received physical therapy for knee pain).  She had recently 
joined ___.  She denied history of eating disorders - no 
anorexia, bulimia, diuretic or laxative abuse.  She does have a 
history of binge eating and was recommended counseling on her 
initial presentation in ___ that she did undertake and now is 
considered under control. She does not have a clinical diagnosis 
of depression.  She has been followed by a therapist for her 
binge eating, has not been hospitalized for mental health issues 
and she is not on any psychotropic medications.

 
Past Medical History:
1)  hypertension
2)  obstructive sleep apnea on CPAP
3)  melanoma of the right shin
4)  history of dermoid cyst found during in ___ fertilization
5)  history of infertility
6)  vitamin D deficiency
7)  history of patellar instability with frequent dislocations
8)  history of Achilles tendinopathy of the left posterior heel
9)  dermatohellosis
10) history of UTIs
11) frequent sinus infections
12) pre-diabetes on metformin with hemoglobin A1c of 5.4%

Her surgical history is significant for:

1)  right dermoid cyst excision and salpingo-oophorectomy via 
    ___ incision.
2)  laparoscopies x 3 for infertility.
3)  laparoscopic cholecystectomy.
4)  tonsillectomy and adenoidectomy at age ___.
5)  ruptured appendix at age ___ via McBurney's incision.
6)  ruptured ectopic, right salpingectomy.
7)  lysis of adhesions x 2
8)  right lower extremity melanoma wide excision ___ years ago.
9)  left Achilles surgery.
10) right knee arthroscopy.

 
Social History:
___
Family History:
Her family history is noted for both parents living father age 
___ with history of coronary artery disease s/p MI with 
angioplasties and stents, prostate and bladder CA; mother with 
no significant health issues; paternal grandfather deceased at 
the age of ___ with acute MI. 
 
Physical Exam:
T=98.2F; BP=131/85mmHg; HR=64x'; RR=18x'; O2 Sat=94% Ra
 GENERAL: AOx3, NAD
 HEENT: Normocephalic, atraumatic. 
 CARDIAC: Regular rate and rhythm, no murmurs/rubs/gallops.  
 LUNGS: No respiratory distress. Clear to auscultation 
bilaterally. No wheezes, rhonchi or rales. 
 ABDOMEN:  Normal bowel sounds, non distended, non-tender to 
palpation. Incisions appear well healed, without erythema or 
secretions
 EXTREMITIES: No clubbing, cyanosis, or edema. 
 
Pertinent Results:
___ 04:18AM BLOOD Hct-37.3
___ 05:11PM BLOOD Hct-40.1
 
Brief Hospital Course:
___ is a ___ woman with class
III morbid obesity and BMI of 49.3 and co-morbidities of
hypertension, obstructive sleep apnea on CPAP, pre-diabetes and
history of gallstones s/p laparoscopic cholecystectomy. She has
been unsuccessful at achieving sustained weight loss by 
non-operative means. After evaluation from our multidisciplinary 
team she was deemed an excellent candidate for laparoscopic 
gastric sleeve. She presented to ___ on ___ for this 
elective procedure.
The patient presented to pre-op on ___ and was evaluated 
by anaesthesia. The patient was taken to the operating room for 
a laparoscopic sleeve gastrectomy. There were no adverse events 
in the operating room; please see the operative note for 
details. Pt was extubated, taken to the PACU until stable, then 
transferred to the ward for observation. 
 Neuro: The patient was alert and oriented throughout 
hospitalization; pain was initially managed with a PCA. Pain was 
very well controlled. The patient was then transitioned to 
crushed oral pain medication once tolerating a stage 3 diet. 
 CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored. 
 Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization. 
 GI/GU/FEN: The patient was initially kept NPO. Afterwards, the 
patient was started on a stage 1 bariatric diet, which the 
patient tolerated well. Subsequently, the patient was advanced 
to stage 2, and then stage 3 diet which the patient was 
tolerating on day of discharge. 
 ID: The patient's fever curves were closely watched for signs 
of infection, of which there were none. 
 HEME: The patient's blood counts were closely watched for signs 
of bleeding, of which there were none. 
 Prophylaxis: The patient received subcutaneous heparin and ___ 
dyne boots were used during this stay and was encouraged to get 
up and ambulate as early as possible. 
 At the time of discharge, the patient was doing well, afebrile 
and hemodynamically stable. The patient was tolerating a 
bariatric stage 3 diet, ambulating, voiding without assistance, 
and pain was well controlled. The patient received discharge 
teaching and follow-up instructions with understanding 
verbalized and agreement with the discharge plan. 
 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. phentermine 37.5 mg oral ASDIR 
2. Valsartan 80 mg PO DAILY 
3. Triamcinolone Acetonide 0.1% Ointment 1 Appl TP ASDIR 
4. Ketoconazole 2%  1 Appl TP ASDIR 
5. MetFORMIN (Glucophage) 500 mg PO DAILY 
6. Ferrous Sulfate 325 mg PO ASDIR 
7. pedi multivit 43-iron fumarate 18 mg iron oral DAILY 
8. Cyanocobalamin 1000 mcg PO DAILY 
9. Vitamin D 1000 UNIT PO DAILY 

 
Discharge Medications:
1.  Acetaminophen (Liquid) 650 mg PO Q6H 
RX *acetaminophen 650 mg/20.3 mL 650 mg by mouth every six (6) 
hours Disp #*812 Milliliter Refills:*0 
2.  Docusate Sodium 100 mg PO BID:PRN constipation 
RX *docusate sodium [Docu] 50 mg/5 mL 10 ml by mouth twice a day 
Refills:*0 
3.  Famotidine 20 mg PO BID 
RX *famotidine 20 mg 1 tablet(s) by mouth twice a day Disp #*60 
Tablet Refills:*0 
4.  Ondansetron 4 mg PO Q8H:PRN nausea Duration: 10 Days 
RX *ondansetron 4 mg 1 tablet(s) by mouth every eight (8) hours 
Disp #*20 Tablet Refills:*0 
5.  OxycoDONE Liquid ___ mg PO Q4H:PRN Pain - Moderate 
RX *oxycodone 5 mg/5 mL 5 mg by mouth every four (4) hours 
Refills:*0 
6.  Ketoconazole 2%  1 Appl TP ASDIR  
7.  pedi multivit 43-iron fumarate 18 mg iron oral DAILY 
please use chewable form of this medication  
8.  Triamcinolone Acetonide 0.1% Ointment 1 Appl TP ASDIR  
9.  Valsartan 80 mg PO DAILY 
Please crush this medication  
10. HELD- Cyanocobalamin 1000 mcg PO DAILY  This medication was 
held. Do not restart Cyanocobalamin until you discuss with your 
nutritionist
11. HELD- Ferrous Sulfate 325 mg PO ASDIR  This medication was 
held. Do not restart Ferrous Sulfate until you discuss with your 
nutritionist
12. HELD- MetFORMIN (Glucophage) 500 mg PO DAILY  This 
medication was held. Do not restart MetFORMIN (Glucophage) until 
you discuss on your next appointment with your PCP
13. HELD- Vitamin D 1000 UNIT PO DAILY  This medication was 
held. Do not restart Vitamin D until you discuss with your 
nutritionist on your next appointment

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Morbid obesity

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Discharge Instructions: Please call your surgeon or return to 
the Emergency Department if you develop a fever greater than 101 
F, shaking chills, chest pain, difficulty breathing, pain with 
breathing, cough, a rapid heartbeat, dizziness, severe abdominal 
pain, pain unrelieved by your pain medication, a change in the 
nature or severity of your pain, severe nausea, vomiting, 
abdominal bloating, severe diarrhea, inability to eat or drink, 
foul smelling or colorful drainage from your incisions, redness, 
swelling from your incisions, or any other symptoms which are 
concerning to you.

Diet: Stay on Stage III diet until your follow up appointment; 
please refer to your work book for detailed instructions. Do not 
self- advance your diet and avoid drinking with a straw or 
chewing gum. To avoid dehydration, remember to sip small amounts 
of fluid frequently throughout the day to reach a goal of 
approximately ___ mL per day. Please note the following signs 
of dehydration: dry mouth, rapid heartbeat, feeling dizzy or 
faint, dark colored urine, infrequent urination. 

Medication Instructions:
Please refer to the medication list provided with your discharge 
paperwork for detailed instruction regarding your home and newly 
prescribed medications.  

Some of the new medications you will be taking include:
1.  Pain medication: You will receive a prescription for liquid 
oxycodone, an opioid pain medication.  This medication will make 
you drowsy and impair your ability to drive a motor vehicle or 
operate machinery safely. You MUST refrain from such activities 
while taking these medications. You may also take acetaminophen 
(Tylenol) for pain management; do not exceed 4000 mg per 24 hour 
period.
2. Constipation: This is a common side effect of opioid pain 
medication.  If you experience constipation, please reduce or 
eliminate opioid pain medication.  You may trial 2 ounces of 
light prune juice and/or a stool softener (i.e. crushed docusate 
sodium tablets), twice daily until you resume a normal bowel 
pattern.  Please stop taking this medication if you develop 
loose stools. Please do not begin taking laxatives including 
until you have discussed it with your nurse or surgeon.
3. Antacids: You will be taking famotidine tablets, 20 mg twice 
daily, for one month. This medicine reduces stomach acid 
production. Please crush.
4. You must not use NSAIDS (non-steroidal anti-inflammatory 
drugs). Examples include, but are not limited to Aleve, 
Arthrotec, aspirin, Bufferin, diclofenac, Ecotrin, etodolac, 
ibuprofen, Indocin, indomethacin, Feldene, ketorolac, 
meclofenamate, meloxicam, Midol, Motrin, nambumetone, Naprosyn, 
Naproxen, Nuprin, oxaprozin, Piroxicam, Relafen, Toradol and 
Voltaren. These agents may cause bleeding and ulcers in your 
digestive system. If you are unclear whether a medication is 
considered an NSAID, please ask call your nurse or ask your 
pharmacist.
5.  Vitamins/ minerals: You may resume a chewable multivitamin, 
however, please discuss when to resume additional vitamin and 
mineral supplements with your bariatric dietitian.

Activity:
You should continue walking frequently throughout the day right 
after surgery; you may climb stairs.  
You may resume moderate exercise at your discretion, but avoid 
performing abdominal exercises or lifting items greater than10 
to 15 pounds for six weeks.

Wound Care:
You may remove any remaining gauze from over your incisions.  
You will have thin paper strips (Steri-Strips) over your 
incision; please, remove any remaining Steri-Strip seven to 10 
days after surgery.   
You may shower 48 hours following your surgery; avoid scrubbing 
your incisions and gently pat them dry.  Avoid tub baths or 
swimming until cleared by your surgeon. 
If there is clear drainage from your incisions, cover with 
clean, dry gauze. 
Please call the doctor if you have increased pain, swelling, 
redness, cloudy, bloody or foul smelling drainage from the 
incision sites. 
Avoid direct sun exposure to the incision area for up to 24 
months.
Do not use any ointments on the incision unless you were told 
otherwise.

 
Followup Instructions:
___